Why Acasti Pharma (ACST) Stock Is Exploding Higher

Acasti Pharma Inc ACST shares are trading higher by 34.3% to $2.35 Tuesday morning after the company announced $7.5 million in private placement equity financing.

Acasti Pharma says the gross proceeds to the company from the private placement were approximately $7.5 million, before deducting fees and expenses.

The company says it currently intends to use the net proceeds from the private placement for clinical trial expenses to further the Phase 3 clinical trial for GTX-104, the Acasti Pharma's lead product candidate, pre-commercial planning, working capital and other general corporate purposes.

According to data from Benzinga Pro, ACST has a 52-week high of $5.05 and a 52-week low of $1.72.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny Stockswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!